FEBBO WILLIAM J 4
4 · OptimizeRx Corp · Filed Jan 18, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
FEBBO WILLIAM J
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2024-01-09+9,628→ 481,028 total - Exercise/Conversion
Restricted Stock Units
2024-01-09−9,628→ 0 total→ Common Stock (9,628 underlying) - Tax Payment
Common Stock
2024-01-09$13.25/sh−2,884$38,213→ 478,144 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.